MODA, FABIO
 Distribuzione geografica
Continente #
AS - Asia 3.834
NA - Nord America 2.289
EU - Europa 2.022
SA - Sud America 491
AF - Africa 111
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.779
Nazione #
US - Stati Uniti d'America 2.158
SG - Singapore 1.246
CN - Cina 1.093
IT - Italia 582
DE - Germania 415
HK - Hong Kong 400
BR - Brasile 390
BD - Bangladesh 258
VN - Vietnam 249
RU - Federazione Russa 235
IN - India 195
GB - Regno Unito 178
FR - Francia 153
NL - Olanda 111
TR - Turchia 75
FI - Finlandia 63
CA - Canada 62
ID - Indonesia 62
KR - Corea 58
SE - Svezia 51
JP - Giappone 47
AR - Argentina 37
ES - Italia 34
MX - Messico 34
IE - Irlanda 32
EG - Egitto 28
CI - Costa d'Avorio 26
DK - Danimarca 26
AU - Australia 24
AT - Austria 23
IQ - Iraq 23
PL - Polonia 17
BE - Belgio 16
EC - Ecuador 16
CH - Svizzera 15
UA - Ucraina 15
PK - Pakistan 14
ZA - Sudafrica 14
MA - Marocco 13
SA - Arabia Saudita 13
JO - Giordania 12
VE - Venezuela 12
TH - Thailandia 11
KE - Kenya 10
CZ - Repubblica Ceca 9
PT - Portogallo 9
PY - Paraguay 9
AE - Emirati Arabi Uniti 7
MY - Malesia 7
NO - Norvegia 7
PE - Perù 7
PS - Palestinian Territory 7
CL - Cile 6
CO - Colombia 6
DZ - Algeria 6
GR - Grecia 6
IL - Israele 6
JM - Giamaica 6
LB - Libano 6
TW - Taiwan 6
UZ - Uzbekistan 6
GT - Guatemala 5
IR - Iran 5
NZ - Nuova Zelanda 5
PH - Filippine 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
LU - Lussemburgo 4
OM - Oman 4
TN - Tunisia 4
UY - Uruguay 4
BB - Barbados 3
BG - Bulgaria 3
BO - Bolivia 3
HN - Honduras 3
PA - Panama 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SV - El Salvador 3
AM - Armenia 2
ET - Etiopia 2
KW - Kuwait 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
PR - Porto Rico 2
QA - Qatar 2
RO - Romania 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
Totale 8.767
Città #
Singapore 522
Hefei 392
Ashburn 307
Hanover 306
San Jose 300
Hong Kong 292
Council Bluffs 183
Milan 157
Dallas 123
Beijing 116
Bengaluru 105
Ho Chi Minh City 93
Los Angeles 93
Southend 90
Lauterbourg 86
New York 85
Moscow 76
Hanoi 70
Istanbul 56
Buffalo 52
Santa Clara 50
Fairfield 49
Guangzhou 49
Seoul 48
Chandler 44
Frankfurt am Main 43
Jakarta 42
Atlanta 40
Naples 38
Seattle 38
São Paulo 37
Helsinki 36
Rome 33
Chicago 30
Shanghai 29
Tokyo 28
Abidjan 26
Cangzhou 25
Dublin 24
Lappeenranta 24
Houston 21
Nuremberg 20
Amsterdam 19
Boardman 19
Columbus 18
Bologna 17
Princeton 17
Ann Arbor 16
Mexico City 16
Wilmington 16
Washington 14
Cairo 13
Rio de Janeiro 13
Tianjin 13
Toronto 13
Woodbridge 13
Cambridge 12
Florence 12
Dearborn 11
Des Moines 11
McAllen 11
Montreal 11
Phoenix 11
Stockholm 11
Sydney 11
Amman 10
Baghdad 10
Barcelona 10
Brooklyn 10
Nairobi 10
Nanjing 10
Pittsburgh 10
Shenzhen 10
Bari 9
Belo Horizonte 9
Groningen 9
London 9
Madrid 9
Tampa 9
Vienna 9
Warsaw 9
Zurich 9
Alexandria 8
Brescia 8
Genoa 8
Guarulhos 8
Hangzhou 8
Melbourne 8
Orem 8
Shenyang 8
Verona 8
Brussels 7
Chennai 7
Da Nang 7
Grand Rapids 7
Guayaquil 7
Haiphong 7
Mumbai 7
Paris 7
Phitsanulok 7
Totale 4.892
Nome #
TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients 394
Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception 373
Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories 295
Biochemical and biophysical comparison of human and mouse beta-2 microglobulin reveals the molecular determinants of low amyloid propensity 276
β2-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression 245
Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in pank2 knock-out mouse model 239
Lewy pathology formation in patient-derived GBA1 Parkinson's disease midbrain organoids 220
Investigating the Molecular Basis of the Aggregation Propensity of the Pathological D76N Mutant of Beta-2 Microglobulin: Role of the Denatured State 209
MM2-Thalamic Creutzfeldt-Jakob Disease : Neuropathological, Biochemical and Transmission Studies Identify a Distinctive Prion Strain 170
Poly-γ-glutamic acid alleviates cytotoxicity and inflammation induced by pre-formed fibrils of α-synuclein in murine primary astrocytes 159
MRI abnormalities found 1 year prior to symptom onset in a case of Creutzfeldt–Jakob disease 132
DNAJB2-related Charcot-Marie-Tooth disease type 2 : Pathomechanism insights and phenotypic spectrum widening 120
PMCA-Based Detection of Prions in the Olfactory Mucosa of Patients With Sporadic Creutzfeldt-Jakob Disease 118
From Protein Misfolding to Dementia: Basic Research, Innovative Diagnosis and Early Biomarkers 116
Bifunctional carbazole derivatives for simultaneous therapy and fluorescence imaging in prion disease murine cell models 115
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays 113
Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies 106
Validation of Revised International Creutzfeldt-Jakob Disease Surveillance Network Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease 104
Impact of seed amplification assay and surface-enhanced Raman spectroscopy combined approach on the clinical diagnosis of Alzheimer's disease 101
Animal Models of Autosomal Recessive Parkinsonism 101
The uptake of tau amyloid fibrils is facilitated by the cellular prion protein and hampers prion propagation in cultured cells 98
Unfolding Mechanism and Fibril Formation Propensity of Human Prion Protein in the Presence of Molecular Crowding Agents 96
Detection of prions in the urine of patients affected by sporadic Creutzfeldt-Jakob disease 95
Sporadic Creutzfeldt-Jakob disease: Real-Time Quaking Induced Conversion (RT-QuIC) assay represents a major diagnostic advance 91
Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob Disease 89
Diagnostic Performance of the α-Synuclein Seed Amplification Assay for Dementia With Lewy Bodies: A Comparison Across 4 Laboratories 88
Infectivity in skeletal muscle of cattle with atypical bovine spongiform encephalopathy 87
Chronic wasting disease and atypical forms of bovine spongiform encephalopathy and scrapie are not transmissible to mice expressing wild-type levels of human prion protein 87
PMCA-generated prions from the olfactory mucosa of patients with Fatal Familial Insomnia cause prion disease in mice 86
Semantic and right temporal variant of FTD: Next generation sequencing genetic analysis on a single-center cohort 86
Induced Pluripotent Stem Cell-Derived Neural Precursors Improve Memory, Synaptic and Pathological Abnormalities in a Mouse Model of Alzheimer’s Disease 86
α-Synuclein distribution in olfactory mucosa and skin nerves in Parkinson disease associated with an EIF4G1 gene mutation 85
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation 84
Exploring the impact of SerpinA3n deficiency on prion strains propagation 84
Extracellular vesicles isolated from adipose tissue-derived mesenchymal stromal cells as carriers for Paclitaxel delivery 84
High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions 84
Prions in the urine of patients with variant Creutzfeldt-Jakob disease 82
Transmission of Norwegian reindeer CWD to sheep by intracerebral inoculation results in an unusual phenotype and prion distribution 82
Molecular subtypes of Alzheimer's disease 81
Different tau fibril types reduce prion level in chronically and de novo infected cells 80
Combined 18F‐FDG PET‐CT markers in dementia with Lewy bodies 79
Use of different RT-QuIC substrates for detecting CWD prions in the brain of Norwegian cervids 78
TDP-43 seeding activity in the olfactory mucosa of patients with amyotrophic lateral sclerosis 75
Approaching the Gut and Nasal Microbiota in Parkinson’s Disease in the Era of the Seed Amplification Assays 75
PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease 72
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 72
Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease 72
Protein Misfolding Cyclic Amplification 71
COVID-19-associated immune-mediated encephalitis mimicking acute-onset Creutzfeldt-Jakob disease 70
The Endoplasmic Reticulum Chaperone GRP78/BiP Modulates Prion Propagation in vitro and in vivo 70
Defined α-synuclein prion-like molecular assemblies spreading in cell culture 69
PMCA-replicated PrPD in urine of vCJD patients maintains infectivity and strain characteristics of brain PrPD: Transmission study 69
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in Phase II Study on GBA-Associated Parkinson’s Disease Patients 68
Grass Plants Bind, Retain, Uptake, and Transport Infectious Prions 68
Seed Amplification Assays as Powerful Tools for Detecting Peripheral Biomarkers in Prion-Like Diseases 65
Treatment with a non-toxic, self-replicating anti-prion delays or prevents prion disease in vivo 64
The Alpha-Synuclein RT-QuIC Products Generated by the Olfactory Mucosa of Patients with Parkinson’s Disease and Multiple System Atrophy Induce Inflammatory Responses in SH-SY5Y Cells 64
Structural and dynamical determinants of a β-sheet-enriched intermediate involved in amyloid fibrillar assembly of human prion protein 63
Hemoglobin mRNA changes in the frontal cortex of patients with neurodegenerative diseases 63
The Role of Prion Protein in Reelin/Dab1 Signaling: Implications for Neurodegeneration 62
Halogenation of the N-Terminus Tyrosine 10 Promotes Supramolecular Stabilization of the Amyloid-β Sequence 7-12 61
Serpin Signatures in Prion and Alzheimer's Diseases 61
Detecting the Undetectable: Exploring the Diagnostic Potential of Protein Misfolding Cyclic Amplification in Human Prion Diseases 58
Advancing Prion Diagnostics: RT-QuIC Applications in Peripheral Tissues 58
Strain-dependent profile of misfolded prion protein aggregates 58
Contributions of Molecular and Optical Techniques to the Clinical Diagnosis of Alzheimer’s Disease 58
Differential overexpression of SERPINA3 in human prion diseases 57
The cellular prion protein increases the uptake and toxicity of TDP-43 fibrils 57
α-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication 56
Synthetic Prion Selection and Adaptation 56
Detection of TDP-43 seeds in CSF of presymptomatic and symptomatic genetic FTD/ALS 56
Enhanced self-assembly of the 7–12 sequence of amyloid-β peptide by tyrosine bromination 54
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment inGBA-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 54
Cell-free amplification of prions: Where do we stand? 53
Tackling amyloidogenesis in Alzheimer's disease with A2V variants of Amyloid-β 53
Sporadic MM-1 Type Creutzfeldt-Jakob disease with hemiballic presentation and no cognitive impairment until death: How New NCJDRSU diagnostic criteria may allow early diagnosis 53
Wondering about pruritus in the fatal familial insomnia 53
Clinical features, pathophysiology and management of fatal familial insomnia 52
Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features 50
Sporadic Fatal Insomnia presenting with agrypnia excitata and rapidly progressive dementia: a case report 50
Synthetic prions and other human neurodegenerative proteinopathies 50
Detection of prion seeding activity in the olfactory mucosa of patients with Fatal Familial Insomnia 49
Peptidomimetics Inspired by α-Synuclein or Its Chaperone αB-Crystallin Differentially Modulate α-Synuclein Aggregation 48
A novel class of potential prion drugs: Preliminary in vitro and in vivo data for multilayer coated gold nanoparticles 47
Brain delivery of AAV9 expressing an anti-PrP monovalent antibody delays prion disease in mice 47
Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases 46
Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy 44
Prion Efficiently Replicates in α-Synuclein Knockout Mice 44
Protein misfolding cyclic amplification 44
Synthetic mammalian prions 42
Protein misfolding cyclic amplification of infectious prions 41
Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases 40
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors 40
Synthetic prions with novel strain-specified properties 39
The cognitive phenotypes of Creutzfeldt-Jakob disease: comparison with secondary metabolic encephalopathy 39
Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene 39
Novel screening approaches for human prion diseases drug discovery 37
Overview of protein misfolding amplification methods and their use in prion disease diagnosis and in investigations of within- and inter-species prion transmission 36
Biomarkers for Lewy body diseases and other alpha-synucleinopathies in biofluids: current evidence and future directions 33
The prion concept and synthetic prions 33
Totale 8.776
Categoria #
all - tutte 22.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.066


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 7 10
2021/2022489 13 13 19 42 46 36 40 36 94 77 50 23
2022/2023208 26 20 20 18 23 38 14 12 17 2 13 5
2023/2024131 2 11 7 11 24 11 8 7 5 7 22 16
2024/20251.844 12 20 11 22 175 105 172 183 153 228 190 573
2025/20266.283 528 636 764 588 379 291 427 346 867 676 781 0
Totale 9.380